Automated description from the Alliance of Genome Resources
Predicted to have AP-2 adaptor complex binding activity and cytoskeletal protein binding activity. Predicted to be involved in clathrin coat assembly and clathrin-dependent endocytosis. Predicted to localize to several cellular components, including the clathrin-coated pit; clathrin-coated vesicle; and nucleoplasm. Is expressed in central nervous system; ganglia; neural retina; and thymus primordium. Orthologous to human FCHO1 (FCH and mu domain containing endocytic adaptor 1).